The 1993 sexually transmitted disease treatment guidelines.
This article will review the 1993 STD Treatment Guidelines of particular importance to dermatologic clinical practice. Topics include STD/HIV prevention, management of sexual partners, STD in persons with HIV co-infection, genital ulcer disease (GUD) including syphilis, herpes simplex virus (HSV) infection, lymphogranuloma venereum (LGV) and chancroid, therapy of nongonococcal (NGU) and chlamydial urethritis and cervicitis, gonococcal (GC) infections, HPV infection, hepatitis B virus (HBV) infection, pediculosis pubis, and scabies.
Department of Medicine (Dermatology), Vanderbilt University Medical Center, Nashville, TN.
D M
DM
Buntin
D002602:Chancroid / Q000188:drug therapy; D002690:Chlamydia Infections / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control; D006558:Herpes Genitalis / Q000188:drug therapy; D006801:Humans; D010373:Lice Infestations / Q000188:drug therapy; D008219:Lymphogranuloma Venereum / Q000188:drug therapy; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D012532:Scabies / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy* / Q000517:prevention & control; D013587:Syphilis / Q000188:drug therapy; D014412:Tumor Virus Infections / Q000188:drug therapy; D014526:Urethritis / Q000188:drug therapy / Q000382:microbiology